These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17650180

  • 1. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
    Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K.
    Parasite Immunol; 2007 Aug; 29(8):387-94. PubMed ID: 17650180
    [Abstract] [Full Text] [Related]

  • 2. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.
    Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ.
    J Infect Dis; 2007 Jan 15; 195(2):279-87. PubMed ID: 17191173
    [Abstract] [Full Text] [Related]

  • 3. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R, Dechavanne C, Sadissou I, d'Almeida T, Bouraima A, Sonon P, Amoussa R, Cottrell G, Le Port A, Theisen M, Remarque EJ, Longacre S, Moutairou K, Massougbodji A, Luty AJF, Nuel G, Migot-Nabias F, Sanni A, Garcia A, Milet J, Courtin D.
    Malar J; 2019 Jun 11; 18(1):194. PubMed ID: 31185998
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A, Chourasia BK, Mehrotra S, Kana IH, Paul G, Panda A, Kaur I, Singh SK, Rathore S, Das A, Gupta P, Kalamuddin M, Gakhar SK, Mohmmed A, Theisen M, Malhotra P.
    Infect Immun; 2018 Aug 11; 86(8):. PubMed ID: 29760216
    [Abstract] [Full Text] [Related]

  • 5. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
    Bang G, Prieur E, Roussilhon C, Druilhe P.
    PLoS One; 2011 Aug 11; 6(12):e28165. PubMed ID: 22145028
    [Abstract] [Full Text] [Related]

  • 6. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE, Nuvor SV, Obboh EK, Acquah FK, Asare K, Singh SK, Boampong JN, Theisen M, Williamson KC.
    Parasit Vectors; 2017 Aug 23; 10(1):395. PubMed ID: 28835262
    [Abstract] [Full Text] [Related]

  • 7. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
    Osier FH, Murungi LM, Fegan G, Tuju J, Tetteh KK, Bull PC, Conway DJ, Marsh K.
    Parasite Immunol; 2010 Mar 23; 32(3):193-201. PubMed ID: 20398182
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
    Infect Immun; 2009 Mar 23; 77(3):1165-74. PubMed ID: 19139189
    [Abstract] [Full Text] [Related]

  • 9. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [Abstract] [Full Text] [Related]

  • 10. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R, Wunderlich G, Ferreira MU.
    J Eukaryot Microbiol; 2001 Dec 04; 48(5):556-64. PubMed ID: 11596920
    [Abstract] [Full Text] [Related]

  • 11. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
    Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ.
    Parasite Immunol; 2003 Jun 04; 25(6):307-12. PubMed ID: 14507328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations.
    Tamborrini M, Stoffel SA, Westerfeld N, Amacker M, Theisen M, Zurbriggen R, Pluschke G.
    Malar J; 2011 Dec 13; 10():359. PubMed ID: 22166048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.